Vasopressin: a novel target for the prevention and retardation of kidney disease?
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vasopressin: a novel target for the prevention and retardation of kidney disease?
Authors
Keywords
-
Journal
Nature Reviews Nephrology
Volume 9, Issue 4, Pages 223-239
Publisher
Springer Nature
Online
2013-02-26
DOI
10.1038/nrneph.2013.22
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cognitive Performance and Dehydration
- (2013) Ana Adan JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Plain-water intake and risk of type 2 diabetes in young and middle-aged women
- (2012) An Pan et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- The J-Curve Revisited
- (2012) Edward J. Filippone et al. Cardiology in Review
- Apelin in the Control of Body Fluid Homeostasis and Cardiovascular Functions
- (2012) Cecile Galanth et al. CURRENT PHARMACEUTICAL DESIGN
- Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
- (2012) A. Abbasi et al. DIABETOLOGIA
- New insights into urea and glucose handling by the kidney, and the urine concentrating mechanism
- (2012) Lise Bankir et al. KIDNEY INTERNATIONAL
- Alcohol and kidney damage: a Janus-faced relationship
- (2012) Elke Schaeffner et al. KIDNEY INTERNATIONAL
- Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease
- (2012) W. E. Boertien et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
- (2012) Vicente E. Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
- (2012) Taka-aki Koshimizu et al. PHYSIOLOGICAL REVIEWS
- Rationale and Design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3-4 Study
- (2011) Vicente E. Torres et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Mild dehydration impairs cognitive performance and mood of men
- (2011) Matthew S. Ganio et al. BRITISH JOURNAL OF NUTRITION
- Antinatriuretic Effect of Vasopressin in Humans Is Amiloride Sensitive, Thus ENaC Dependent
- (2011) A. Blanchard et al. Clinical Journal of the American Society of Nephrology
- Urine Volume and Change in Estimated GFR in a Community-Based Cohort Study
- (2011) W. F. Clark et al. Clinical Journal of the American Society of Nephrology
- Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Three Years' Experience
- (2011) E. Higashihara et al. Clinical Journal of the American Society of Nephrology
- Low Water Intake and Risk for New-Onset Hyperglycemia
- (2011) R. Roussel et al. DIABETES CARE
- Reduced Insulin Secretion and Nocturnal Dipping of Blood Pressure Are Associated with a Disturbed Circadian Pattern of Urine Excretion in Metabolic Syndrome
- (2011) Dominique Guerrot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Plasma Copeptin, A Unifying Factor behind the Metabolic Syndrome
- (2011) Sofia Enhörning et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mild Dehydration Affects Mood in Healthy Young Women
- (2011) Lawrence E. Armstrong et al. JOURNAL OF NUTRITION
- Copeptin Levels Associate with Cardiovascular Events in Patients with ESRD and Type 2 Diabetes Mellitus
- (2011) W. Fenske et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease
- (2011) Maria V. Irazabal et al. KIDNEY INTERNATIONAL
- Dehydration Influences Mood and Cognition: A Plausible Hypothesis?
- (2011) David Benton Nutrients
- Novel Agents for the Treatment of Hyponatremia
- (2010) Nadia Ferguson-Myrthil Cardiology in Review
- Plasma Copeptin and the Risk of Diabetes Mellitus
- (2010) Sofia Enhörning et al. CIRCULATION
- Water Prescription in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study
- (2010) C. J. Wang et al. Clinical Journal of the American Society of Nephrology
- Copeptin, a Surrogate Marker of Vasopressin, Is Associated with Disease Severity in Autosomal Dominant Polycystic Kidney Disease
- (2010) E. Meijer et al. Clinical Journal of the American Society of Nephrology
- Potentially Modifiable Factors Affecting the Progression of Autosomal Dominant Polycystic Kidney Disease
- (2010) V. E. Torres et al. Clinical Journal of the American Society of Nephrology
- J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial
- (2010) S. Bangalore et al. EUROPEAN HEART JOURNAL
- Fluid and nutrient intake and risk of chronic kidney disease
- (2010) GIOVANNI FM STRIPPOLI et al. NEPHROLOGY
- Effects of the vasopressin agonist terlipressin on plasma cAMP and ENaC excretion in the urine in patients with cirrhosis and water retention
- (2010) Aleksander Krag et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Cigarette Use and Cardiovascular Risk in Chronic Kidney Disease: An Unappreciated Modifiable Lifestyle Risk Factor
- (2010) Austin G. Stack et al. SEMINARS IN DIALYSIS
- Does having a drink help you think? 6–7-Year-old children show improvements in cognitive performance from baseline to test after having a drink of water
- (2009) Caroline J. Edmonds et al. APPETITE
- Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats
- (2009) Tadashi Okada et al. Clinical and Experimental Nephrology
- A Case for Water in the Treatment of Polycystic Kidney Disease
- (2009) V. E. Torres et al. Clinical Journal of the American Society of Nephrology
- Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure
- (2009) Maria D’Apolito et al. JOURNAL OF CLINICAL INVESTIGATION
- V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin–angiotensin system inhibition in rats with renal mass reduction
- (2009) Norberto Perico et al. KIDNEY INTERNATIONAL
- Cyclic nucleotide signaling in polycystic kidney disease
- (2009) Xiaofang Wang et al. KIDNEY INTERNATIONAL
- Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort
- (2009) Esther Meijer et al. KIDNEY INTERNATIONAL
- Copeptin, a Surrogate Marker of Vasopressin, Is Associated With Accelerated Renal Function Decline in Renal Transplant Recipients
- (2009) Esther Meijer et al. TRANSPLANTATION
- Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R)
- (2009) Davide Bolignano et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome
- (2008) Aleksander Krag et al. ADVANCES IN THERAPY
- Role of Vasopressin Antagonists
- (2008) V. E. Torres Clinical Journal of the American Society of Nephrology
- Gender and renal function influence plasma levels of copeptin in healthy individuals
- (2008) Sanjay S. Bhandari et al. CLINICAL SCIENCE
- Familiäre proximal-tubuläre Azotämie: Erhöhte Harnstoff-Plasmakonzentration bei normaler Nierenfunktion
- (2008) T. Armsen et al. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
- Nighttime Blood Pressure and Nocturnal Dipping Are Associated With Daytime Urinary Sodium Excretion in African Subjects
- (2008) Lise Bankir et al. HYPERTENSION
- Impact of Solute Intake on Urine Flow and Water Excretion
- (2008) T. Berl JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sodium Excretion in Response to Vasopressin and Selective Vasopressin Receptor Antagonists
- (2008) J. Perucca et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Just Add Water
- (2008) D. Negoianu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Non-peptide arginine-vasopressin antagonists: the vaptans
- (2008) Guy Decaux et al. LANCET
- Essential role of vasopressin-regulated urea transport processes in the mammalian kidney
- (2008) Robert A. Fenton PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Cloning and identification of an oxytocin/vasopressin-like receptor and its ligand from insects
- (2008) E. Stafflinger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic variation in the vasopressin receptor 1a gene (AVPR1A) associates with pair-bonding behavior in humans
- (2008) H. Walum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vasopressin Antagonists in Polycystic Kidney Disease
- (2008) Vicente E. Torres SEMINARS IN NEPHROLOGY
- Vasopressin Receptor Mutations in Nephrogenic Diabetes Insipidus
- (2008) Daniel G. Bichet SEMINARS IN NEPHROLOGY
- Copeptin: clinical use of a new biomarker
- (2008) Nils G. Morgenthaler et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Smoking: A Risk Factor for Progression of Chronic Kidney Disease and for Cardiovascular Morbidity and Mortality in Renal Patients Absence of Evidence or Evidence of Absence?
- (2007) S. R. Orth et al. Clinical Journal of the American Society of Nephrology
- Vasopressin Directly Regulates Cyst Growth in Polycystic Kidney Disease
- (2007) X. Wang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search